Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability-Reference-Cited by-同舟云学术

Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability

Published:2015-10 Issue:4 Volume:43 Page:727-738
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Lee Jacob S.,Tato Cristina M.,Joyce-Shaikh Barbara,Gulen Muhammet F.,Cayatte Corinne,Chen Yi,Blumenschein Wendy M.,Judo Michael,Ayanoglu Gulesi,McClanahan Terrill K.,Li Xiaoxia,Cua Daniel J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference48 articles.

1. Interleukin-23 drives intestinal inflammation through direct activity on T cells;Ahern;Immunity,2010

2. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells;Awasthi;J. Immunol.,2009

3. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology;Buonocore;Nature,2010

4. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo;Clayburgh;J. Clin. Invest.,2005

5. Innate IL-17-producing cells: the sentinels of the immune system;Cua;Nat. Rev. Immunol.,2010

Cited by 580 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the mosaic of inflammatory bowel disease: Illuminating insights with single-cell RNA technology;Computational and Structural Biotechnology Journal;2024-12

2. PARP1 inactivation increases regulatory T / Th17 cell proportion in intestinal inflammation. Role of HMGB1;Immunology Letters;2024-12

3. SPH7854, a gut-limited RORγt antagonist, ameliorates TNBS-induced experimental colitis in rat;International Immunopharmacology;2024-10

4. Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies;Expert Opinion on Drug Safety;2024-09-12

5. Subpopulation dynamics of T and B lymphocytes in Sjögren’s syndrome: implications for disease activity and treatment;Frontiers in Immunology;2024-09-03